Atrial fibrillation (AF) is a cardiac arrhythmia most prevalent in older age groups and with underlying structural heart disease. However, it can occasionally present in younger, otherwise healthy ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

Twinkling lights, family gatherings and holiday cheer often come with indulgent meals and celebratory drinks. But ...

Researchers sought to determine the ability of a validated ECG-based AI model for AF risk prediction to determine future incidence of HF and stroke.

Michigan detects heart disease using an AI model that analyzes standard EKGs to identify coronary microvascular dysfunction noninvasively.

Rising rates of heart rhythm problems are colliding with an aging population and crowded hospitals. At the same time, many ...

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...

After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram ...

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...